Metraipolis › archive › dc_7ab75cc6b7ed
A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance — Europe PMC PMID:42843344
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42843344
- DOI
- 10.1016/j.xcrm.2026.103095
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T07:07:41.029Z
- SHA-256 of the archived text
c0e046de44b10eb1f6f145a5d03c9a7a25262b08d96884b88873b21e759cc45d- Stable URL of this page
https://metraipolis.com/documento/dc_7ab75cc6b7ed
How to cite
A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance — Europe PMC PMID:42843344 — Europe PMC (en), https://europepmc.org/article/MED/42843344 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ab75cc6b7ed (Metraipolis archive dc_7ab75cc6b7ed, sha256 c0e046de44b10eb1f6f145a5d03c9a7a25262b08d96884b88873b21e759cc45d)
BibTeX
@misc{dc7ab75cc6b7ed,
title = {A standardized patient-derived glioblastoma organoid platform for evaluating radiotherapy efficacy and overcoming resistance — Europe PMC PMID:42843344},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42843344},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ab75cc6b7ed; sha256 c0e046de44b10eb1f6f145a5d03c9a7a25262b08d96884b88873b21e759cc45d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42843344. Agents can read the archived copy with the MCP tool read_document.